标题
Novel Allosteric Modulators of G Protein-coupled Receptors
作者
关键词
-
出版物
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 290, Issue 32, Pages 19478-19488
出版商
American Society for Biochemistry & Molecular Biology (ASBMB)
发表日期
2015-06-23
DOI
10.1074/jbc.r115.662759
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pharmacological folding chaperones act as allosteric ligands of Frizzled4
- (2015) Serena F Generoso et al. Nature Chemical Biology
- Advancing the Drug Discovery and Development Process
- (2014) K. C. Nicolaou ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Structure of Class B GPCRs: new horizons for drug discovery
- (2014) Andrea Bortolato et al. BRITISH JOURNAL OF PHARMACOLOGY
- Chemical Biology Methods for Investigating G Protein-Coupled Receptor Signaling
- (2014) Thomas Huber et al. CHEMISTRY & BIOLOGY
- Academic drug discovery centres: the economic and organisational sustainability of an emerging model
- (2014) Henriette Schultz Kirkegaard et al. DRUG DISCOVERY TODAY
- Allosteric Modulation of β-Arrestin-biased Angiotensin II Type 1 Receptor Signaling by Membrane Stretch
- (2014) Wei Tang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Synthesis and Pharmacological Evaluation of Analogues of Benzyl Quinolone Carboxylic Acid (BQCA) Designed to Bind Irreversibly to an Allosteric Site of the M1 Muscarinic Acetylcholine Receptor
- (2014) Briana J. Davie et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure of class C GPCR metabotropic glutamate receptor 5 transmembrane domain
- (2014) Andrew S. Doré et al. NATURE
- The ensemble nature of allostery
- (2014) Hesam N. Motlagh et al. NATURE
- A potentiator of orthosteric ligand activity at GLP-1R acts via covalent modification
- (2014) Whitney M Nolte et al. Nature Chemical Biology
- An allosteric modulator to control endogenous G protein-coupled receptors with light
- (2014) Silvia Pittolo et al. Nature Chemical Biology
- Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders
- (2014) P. Jeffrey Conn et al. NATURE REVIEWS DRUG DISCOVERY
- Separation of on-target efficacy from adverse effects through rational design of a bitopic adenosine receptor agonist
- (2014) C. Valant et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structure of a Class C GPCR Metabotropic Glutamate Receptor 1 Bound to an Allosteric Modulator
- (2014) H. Wu et al. SCIENCE
- Fluorine-19 NMR of integral membrane proteins illustrated with studies of GPCRs
- (2013) Tatiana Didenko et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Structure of class B GPCR corticotropin-releasing factor receptor 1
- (2013) Kaspar Hollenstein et al. NATURE
- Activation and allosteric modulation of a muscarinic acetylcholine receptor
- (2013) Andrew C. Kruse et al. NATURE
- Signalling bias in new drug discovery: detection, quantification and therapeutic impact
- (2013) Terry Kenakin et al. NATURE REVIEWS DRUG DISCOVERY
- Emerging paradigms in GPCR allostery: implications for drug discovery
- (2013) Denise Wootten et al. NATURE REVIEWS DRUG DISCOVERY
- Structure of the CCR5 Chemokine Receptor-HIV Entry Inhibitor Maraviroc Complex
- (2013) Q. Tan et al. SCIENCE
- A Fully Human, Allosteric Monoclonal Antibody That Activates the Insulin Receptor and Improves Glycemic Control
- (2012) Vinay Bhaskar et al. DIABETES
- XMetA, an allosteric monoclonal antibody to the insulin receptor, improves glycaemic control in mice with diet-induced obesity
- (2012) V. Bhaskar et al. DIABETES OBESITY & METABOLISM
- Biased Signaling Pathways in 2-Adrenergic Receptor Characterized by 19F-NMR
- (2012) J. J. Liu et al. SCIENCE
- The Best of Both Worlds? Bitopic Orthosteric/Allosteric Ligands of G Protein–Coupled Receptors
- (2011) Celine Valant et al. Annual Review of Pharmacology and Toxicology
- Molecular Mechanism of β-Arrestin-Biased Agonism at Seven-Transmembrane Receptors
- (2011) Eric Reiter et al. Annual Review of Pharmacology and Toxicology
- “Molecular Switches” on mGluR Allosteric Ligands That Modulate Modes of Pharmacology
- (2011) Michael R. Wood et al. BIOCHEMISTRY
- Crystal structure of the β2 adrenergic receptor–Gs protein complex
- (2011) Søren G. F. Rasmussen et al. NATURE
- Trends in the exploitation of novel drug targets
- (2011) Mathias Rask-Andersen et al. NATURE REVIEWS DRUG DISCOVERY
- Allostery in GPCRs: ‘MWC’ revisited
- (2011) Meritxell Canals et al. TRENDS IN BIOCHEMICAL SCIENCES
- Discovery of a Novel Chemical Class of mGlu5 Allosteric Ligands with Distinct Modes of Pharmacology
- (2010) Alexis S. Hammond et al. ACS Chemical Neuroscience
- Discovery of molecular switches within the ADX-47273 mGlu5 PAM scaffold that modulate modes of pharmacology to afford potent mGlu5 NAMs, PAMs and partial antagonists
- (2010) Jeffrey P. Lamb et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A common intracellular allosteric binding site for antagonists of the CXCR2 receptor
- (2010) K Salchow et al. BRITISH JOURNAL OF PHARMACOLOGY
- Rational design of dualsteric GPCR ligands: quests and promise
- (2010) Klaus Mohr et al. BRITISH JOURNAL OF PHARMACOLOGY
- Kinetic Approach to Pathway Attenuation Using XOMA 052, a Regulatory Therapeutic Antibody That Modulates Interleukin-1β Activity
- (2010) Marina K. Roell et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Virtual Screening Hit Reveals New Possibilities for Developing Group III Metabotropic Glutamate Receptor Agonists
- (2010) Chelliah Selvam et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Novel Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Reveals Chemical and Functional Diversity and In Vivo Activity in Rat Behavioral Models of Anxiolytic and Antipsychotic Activity
- (2010) A. L. Rodriguez et al. MOLECULAR PHARMACOLOGY
- A critical pocket close to the glutamate binding site of mGlu receptors opens new possibilities for agonist design
- (2010) Francine C. Acher et al. NEUROPHARMACOLOGY
- Allosteric modulation of metabotropic glutamate receptors: Structural insights and therapeutic potential
- (2010) Karen J. Gregory et al. NEUROPHARMACOLOGY
- Seven Transmembrane Receptors as Shapeshifting Proteins: The Impact of Allosteric Modulation and Functional Selectivity on New Drug Discovery
- (2010) T. Kenakin et al. PHARMACOLOGICAL REVIEWS
- Beyond Desensitization: Physiological Relevance of Arrestin-Dependent Signaling
- (2010) L. M. Luttrell et al. PHARMACOLOGICAL REVIEWS
- G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function
- (2009) Graeme Milligan BRITISH JOURNAL OF PHARMACOLOGY
- Molecular Mechanisms of Action and In Vivo Validation of an M4 Muscarinic Acetylcholine Receptor Allosteric Modulator with Potential Antipsychotic Properties
- (2009) Katie Leach et al. NEUROPSYCHOPHARMACOLOGY
- A Novel Mechanism of G Protein-coupled Receptor Functional Selectivity
- (2008) Celine Valant et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification of a Putative Intracellular Allosteric Antagonist Binding-Site in the CXC Chemokine Receptors 1 and 2
- (2008) D. J. Nicholls et al. MOLECULAR PHARMACOLOGY
- Amiloride Derivatives and a Nonpeptidic Antagonist Bind at Two Distinct Allosteric Sites in the Human Gonadotropin-Releasing Hormone Receptor
- (2008) L. H. Heitman et al. MOLECULAR PHARMACOLOGY
- Conformational Rearrangements and Signaling Cascades Involved in Ligand-Biased Mitogen-Activated Protein Kinase Signaling through the 1-Adrenergic Receptor
- (2008) S. Galandrin et al. MOLECULAR PHARMACOLOGY
- Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders
- (2008) P. Jeffrey Conn et al. NATURE REVIEWS DRUG DISCOVERY
- Allosteric modulation of the muscarinic M4 receptor as an approach to treating schizophrenia
- (2008) W. Y. Chan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Allostery: an illustrated definition for the ‘second secret of life’
- (2008) Aron W. Fenton TRENDS IN BIOCHEMICAL SCIENCES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started